RECRUITINGNA

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.

Sponsor

University of Michigan

Enrollment

900 participants

Sites

1 locations

Start Date

December 2025

Completion

August 2030

Eye DiseasesVisual ImpairmentGlaucomaStandard optometric examinationTechnology enhanced eye disease detection protocol

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

900

participants

Sites

locations

Duration

4.7 years

total trial span

Rate

pts/month needed

Dec 2025Month 9 of 56Aug 2030

16% of trial timeline elapsed47 months to primary endpoint

At 1 sites, each site needs to enroll approximately 16.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Rate of vision threatening eye disease (glaucoma/suspected glaucoma, visually significant cataract, diabetic retinopathy)

Visit 1(day 1)

Rate of glaucoma/suspected glaucoma

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGNA

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

Sponsor

University of Michigan

Enrollment

900 participants

Sites

1 locations

Start Date

December 2025

Completion

August 2030

Eye DiseasesVisual ImpairmentGlaucomaStandard optometric examinationTechnology enhanced eye disease detection protocol

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

900

participants

Sites

locations

Duration

4.7 years

total trial span

Rate

pts/month needed

Dec 2025Month 9 of 56Aug 2030

16% of trial timeline elapsed47 months to primary endpoint

At 1 sites, each site needs to enroll approximately 16.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Rate of vision threatening eye disease (glaucoma/suspected glaucoma, visually significant cataract, diabetic retinopathy)

Visit 1(day 1)

Rate of glaucoma/suspected glaucoma

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

18 Years

Sex

all

Healthy Volunteers

View full criteria

Inclusion Criteria:

• Speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian or Tagalog

Exclusion Criteria:

* significant eye pain
* sudden decrease in vision within one week
* binocular diplopia
* cognitive impairment
* pregnancy
* previously declined participation

Ask AI

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)